13725-38-7Relevant articles and documents
KRAS G12C Inhibitor compound and application thereof
-
Paragraph 0141-0142; 0146-0148, (2021/05/12)
The invention provides a KRAS G12C inhibitor compound and an application thereof, and particularly provides a compound as shown in a formula (I), and an optical isomer, a hydrate, a solvate or pharmaceutically acceptable salt thereof. The compound can be used as a KRAS G12C inhibitor and is used for treating diseases related to the activity or expression quantity of KRAS G12C.
Compounds specific to adenosine A1 receptors and uses thereof
-
, (2008/06/13)
This invention pertains to compounds which specifically inhibit the adenosine A1 receptor and the use of these compounds to treat a disease associated with A1 adenosine receptors in a subject.